Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 4, pp. 715-727
Open Access | Times Cited: 18

Showing 18 citing articles:

Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
Kazi Ishtiak‐Ahmed, Katherine L. Musliner, Kaj Sparle Christensen, et al.
American Journal of Psychiatry (2023) Vol. 181, Iss. 1, pp. 47-56
Closed Access | Times Cited: 17
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex
Maria Antonietta De Luca, Antonina Luca, A. Messina, et al.
Journal of Affective Disorders (2025)
Closed Access
Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends
Hossein Karami, Reza Mehrizi, Mohammad Effatpanah, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
Gabriela Hjell, Jaroslav Rokicki, Attila Szabó, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Is Pilates effective in improving depressive disorders? A comprehensive overview
F Legnani, Lorenzo Tassi, Teresa Surace, et al.
International Clinical Psychopharmacology (2024) Vol. 40, Iss. 2, pp. 53-61
Open Access | Times Cited: 2
Glial-restricted precursors stimulate endogenous cytogenesis and effectively recover emotional deficits in a model of cytogenesis ablation
Joana Martins‐Macedo, Bruna Araújo, Sandra I. Anjo, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 7, pp. 2185-2198
Open Access | Times Cited: 2
The clinical perspective on late-onset depression in European real-world treatment settings
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology (2024) Vol. 84, pp. 59-68
Open Access | Times Cited: 2
Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark
Kazi Ishtiak‐Ahmed, Kaj Sparle Christensen, Christiane Gasse
Journal of Affective Disorders (2023) Vol. 334, pp. 21-25
Open Access | Times Cited: 6
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions
M. I. Kuzin, Ekkehard Haen, Nazar Kuzo, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 2, pp. 246-251
Open Access | Times Cited: 2
Comparative effectiveness of selective serotonin reuptake inhibitors (SSRIs) for depression in 43,061 older adults with chronic somatic diseases: A Danish target trial emulation study
Kazi Ishtiak‐Ahmed, Christopher Rohde, Christian Otte, et al.
General Hospital Psychiatry (2024) Vol. 87, pp. 83-91
Open Access | Times Cited: 1
Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
Mei Gao, Hui Ma, Tianbin Liu, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14026-e14026
Open Access | Times Cited: 3
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 105-114
Open Access | Times Cited: 2
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Journal of Affective Disorders (2022) Vol. 312, pp. 225-234
Open Access | Times Cited: 3
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
Fabio Panariello, Siegfried Kasper, Joseph Zohar, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 5, pp. 439-448
Closed Access | Times Cited: 3
Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease
Raphael Wurm, Sigrid Klotz, Astrid C. Erber, et al.
JAMA Neurology (2024)
Closed Access
Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions
Wei Zheng, Li-Mei Gu, Xin-Hu Yang, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 2, pp. 145-150
Closed Access | Times Cited: 2
The Toxicity Potential of Antidepressants and Antipsychotics in Relation to Other Medication and Alcohol: A Naturalistic and Retrospective Study
Marleen Margret Mignon Swoboda, Lucie Bartova, Marlene Dremel, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 1
Glial-Restricted Precursors stimulate endogenous cytogenesis and effectively recover emotional deficits in a model of cytogenesis ablation
Luísa Pinto, Joana Martins‐Macedo, Bruna Araújo, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top